Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.

Source:http://linkedlifedata.com/resource/pubmed/id/15492768

Download in:

View as

General Info

PMID
15492768